India registers 2.34 lakh COVID-19 cases, 1,341 deaths in past 24 hours; active cases cross 16 lakh

-

New Delhi: A record single-day rise of 2,34,692 COVID-19 cases and 1,341 fatalities have pushed India's overall count to 1,45,26,609 and the toll to 1,75,649, the health ministry said on Saturday.

The case fatality rate has further dropped to 1.21 percent.

The number of active coronavirus cases in the country has surpassed the 16-lakh mark, the ministry's data updated at 8 am showed.

Registering a steady increase for the 38th day in a row, the tally of active COVID-19 cases has climbed to 16,79,740 in the country, accounting for 11.56 percent of its total caseload.

The number of people who have recuperated from the disease has gone up to 1,26,71,220 thereby taking the national COVID-19 recovery rate to 87.23 percent, the data stated.

India's COVID-19 tally had crossed the 20-lakh mark on 7 August, 30 lakh on 23 August, 40 lakh on 5 September and 50 lakh on 16 September.

It went past 60 lakh on 28 September, 70 lakh on 11 October, crossed 80 lakh on 29 October, 90 lakh on 20 November and surpassed the one-crore mark on 19 December.

According to the Indian Council of Medical Research (ICMR), 26,49,72,022 samples have so far been tested for the viral disease, including 14,95,397 on Friday.

Of the fresh infections, Maharashtra reported 63,729, followed by Uttar Pradesh (27,426) and Delhi (19,486), according to the data. All three states registered the highest daily spike in the number of coronavirus cases since the outbreak of the pandemic last year.

West Bengal, where Assembly polls are underway, also recorded the highest-ever daily jump of 6,910 cases.

Maharashtra also reported the maximum number of fresh casualties at 398, followed by Delhi (141), Chhattisgarh (138), Uttar Pradesh (103), Gujarat (94), Karnataka (78), Madhya Pradesh (60), Punjab (50), Tamil Nadu (33) and Rajasthan (31).



from Firstpost India Latest News https://ift.tt/3ecEfcf
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more